<DOC>
	<DOCNO>NCT01809808</DOCNO>
	<brief_summary>The purpose study evaluate hormone value marker disease activity cohort patient acromegaly time diagnosis prospectively surgical treatment . This study design determine blood level growth hormone relate hormone cardiovascular risk marker well sign symptom disease diagnosis parameter change time surgical therapy . The investigator also obtain hormonal data group 50 healthy subject study oral glucose tolerance test ( OGTT ) . These data provide comparison group acromegaly subject .</brief_summary>
	<brief_title>A Prospective Study Outcome After Therapy Acromegaly</brief_title>
	<detailed_description>Surgical removal pituitary tumor usual first form treatment offer , curative approximately 70 % patient . If adequately treat , disease significant morbidity largely due development hypertension , diabetes malignancy well possible loss vision neurologic complication large pituitary mass . Inadequately treated acromegaly also associate mortality rate 2-3 fold general population . All mechanisms responsible increase morbidity mortality acromegaly well biochemical criterion use treatment order normalize increase morbidity mortality know . This study aim follow patient acromegaly prospectively active disease treatment order identify factor .</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Acromegaly Subjects Adult male female . Ages 18 . Presenting PI one subinvestigators evaluation acromegaly . Must biochemical diagnosis acromegaly consist elevate serum insulinlike growth factor 1 ( IGF1 ) level . Supportive although required entry elevate growth hormone ( GH ) level failure GH suppress normally oral glucose administration . Willingness participate study 's procedure . Subjects unwilling comply procedure outline study . Subjects ability fully comprehend nature study , follow instruction , and/or cooperate study procedure Are unwilling provide inform consent participate study . Healthy Subjects Adult male female . Ages 18 . Responding ad participation word mount . No medical problem , medication , stable weight 3 month prior study . Willingness participate study 's procedure . Subjects unwilling comply procedure outline study . Subjects ability fully comprehend nature study , follow instruction , and/or cooperate study procedure Are unwilling provide inform consent participate study . Failure meet inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acromegaly</keyword>
	<keyword>Pituitary tumor</keyword>
</DOC>